BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21333515)

  • 1. Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: evidence for estrogen receptor β-mediated osteogenic action of medicarpin.
    Bhargavan B; Singh D; Gautam AK; Mishra JS; Kumar A; Goel A; Dixit M; Pandey R; Manickavasagam L; Dwivedi SD; Chakravarti B; Jain GK; Ramachandran R; Maurya R; Trivedi A; Chattopadhyay N; Sanyal S
    J Nutr Biochem; 2012 Jan; 23(1):27-38. PubMed ID: 21333515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats.
    Gautam AK; Bhargavan B; Tyagi AM; Srivastava K; Yadav DK; Kumar M; Singh A; Mishra JS; Singh AB; Sanyal S; Maurya R; Manickavasagam L; Singh SP; Wahajuddin W; Jain GK; Chattopadhyay N; Singh D
    J Nutr Biochem; 2011 Apr; 22(4):318-27. PubMed ID: 20579866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-Demethoxy-medicarpin promotes peak bone mass achievement and has bone conserving effect in ovariectomized mice: Positively regulates osteoblast functions and suppresses osteoclastogenesis.
    Goel A; Raghuvanshi A; Kumar A; Gautam A; Srivastava K; Kureel J; Singh D
    Mol Cell Endocrinol; 2015 Aug; 411():155-66. PubMed ID: 25957087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daidzein stimulates osteogenesis facilitating proliferation, differentiation, and antiapoptosis in human osteoblast-like MG-63 cells via estrogen receptor-dependent MEK/ERK and PI3K/Akt activation.
    Jin X; Sun J; Yu B; Wang Y; Sun WJ; Yang J; Huang SH; Xie WL
    Nutr Res; 2017 Jun; 42():20-30. PubMed ID: 28633868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
    Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
    Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein induces oestrogen receptor-α gene expression in osteoblasts through the activation of mitogen-activated protein kinases/NF-κB/activator protein-1 and promotes cell mineralisation.
    Liao MH; Tai YT; Cherng YG; Liu SH; Chang YA; Lin PI; Chen RM
    Br J Nutr; 2014 Jan; 111(1):55-63. PubMed ID: 23829885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling.
    Bhargavan B; Gautam AK; Singh D; Kumar A; Chaurasia S; Tyagi AM; Yadav DK; Mishra JS; Singh AB; Sanyal S; Goel A; Maurya R; Chattopadhyay N
    J Cell Biochem; 2009 Oct; 108(2):388-99. PubMed ID: 19598169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
    Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
    Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
    Sharan K; Mishra JS; Swarnkar G; Siddiqui JA; Khan K; Kumari R; Rawat P; Maurya R; Sanyal S; Chattopadhyay N
    J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice.
    Tyagi AM; Gautam AK; Kumar A; Srivastava K; Bhargavan B; Trivedi R; Saravanan S; Yadav DK; Singh N; Pollet C; Brazier M; Mentaverri R; Maurya R; Chattopadhyay N; Goel A; Singh D
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):101-9. PubMed ID: 20570709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel therapeutic approach with Caviunin-based isoflavonoid that en routes bone marrow cells to bone formation via BMP2/Wnt-β-catenin signaling.
    Kushwaha P; Khedgikar V; Gautam J; Dixit P; Chillara R; Verma A; Thakur R; Mishra DP; Singh D; Maurya R; Chattopadhyay N; Mishra PR; Trivedi R
    Cell Death Dis; 2014 Sep; 5(9):e1422. PubMed ID: 25232676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of isoflavones on bone-nodule formation in rat calvaria osteoblasts in vitro.
    Chang H; Jin TY; Jin WF; Gu SZ; Zhou YF
    Biomed Environ Sci; 2003 Mar; 16(1):83-9. PubMed ID: 12747011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts.
    Chen JR; Lazarenko OP; Haley RL; Blackburn ML; Badger TM; Ronis MJ
    J Bone Miner Res; 2009 Feb; 24(2):221-30. PubMed ID: 18847333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
    Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
    Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
    De Wilde A; Lieberherr M; Colin C; Pointillart A
    J Cell Physiol; 2004 Aug; 200(2):253-62. PubMed ID: 15174095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite Function of ERα and ERβ in Controlling 17β-Estradiol-mediated Osteogenesis in Osteoblasts.
    Wang YX; Li M; Zhang HQ; Tang MX; Guo CF; Deng A; Chen Y; Xiao LG
    Arch Med Res; 2016 May; 47(4):255-61. PubMed ID: 27664484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts.
    Swarnkar G; Sharan K; Siddiqui JA; Mishra JS; Khan K; Khan MP; Gupta V; Rawat P; Maurya R; Dwivedi AK; Sanyal S; Chattopadhyay N
    Br J Pharmacol; 2012 Mar; 165(5):1526-42. PubMed ID: 21864313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.
    Zhou S; Zilberman Y; Wassermann K; Bain SD; Sadovsky Y; Gazit D
    J Cell Biochem Suppl; 2001; Suppl 36():144-55. PubMed ID: 11455579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen receptor alpha- and beta-selective substances in the metaphysis of the tibia and on serum parameters of bone and fat tissue metabolism of ovariectomized rats.
    Seidlová-Wuttke D; Prelle K; Fritzemeier KH; Wuttke W
    Bone; 2008 Nov; 43(5):849-55. PubMed ID: 18708178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicarpin, a Natural Pterocarpan, Heals Cortical Bone Defect by Activation of Notch and Wnt Canonical Signaling Pathways.
    Dixit M; Raghuvanshi A; Gupta CP; Kureel J; Mansoori MN; Shukla P; John AA; Singh K; Purohit D; Awasthi P; Singh D; Goel A
    PLoS One; 2015; 10(12):e0144541. PubMed ID: 26657206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.